Back to top
more

Elevance Health, Inc. (ELV)

(Delayed Data from NYSE)

$417.86 USD

417.86
1,931,027

+3.85 (0.93%)

Updated Nov 4, 2024 04:00 PM ET

After-Market: $417.84 -0.02 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Elevance (ELV) Q4 Earnings Beat on Premium Growth, Dividend Hiked

by Zacks Equity Research

Elevance Health (ELV) expects 2024 premium revenues to remain in line with the 2023 level.

Elevance Health (ELV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Elevance Health (ELV) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Elevance Health (ELV) delivered earnings and revenue surprises of 1.26% and 1.51%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Countdown to Elevance Health (ELV) Q4 Earnings: Wall Street Forecasts for Key Metrics

by Zacks Equity Research

Get a deeper insight into the potential performance of Elevance Health (ELV) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Can Higher Costs Affect Elevance Health's (ELV) Q4 Earnings?

by Zacks Equity Research

Elevance Health's (ELV) fourth-quarter results are likely to reflect higher premiums and product revenues.

ELV or HQY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ELV vs. HQY: Which Stock Is the Better Value Option?

Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?

by Zacks Equity Research

Here is how Elevance Health (ELV) and Axonics Modulation Technologies (AXNX) have performed compared to their sector so far this year.

Why You Should Retain Elevance (ELV) Stock in Your Portfolio

by Zacks Equity Research

Elevance's (ELV) Carelon unit is expected to benefit from improving performance in the Behavioral Health business and post-acute care services.

Why Elevance Health (ELV) is a Top Momentum Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Elevance Health (ELV) Stock Drops Despite Market Gains: Important Facts to Note

by Zacks Equity Research

In the closing of the recent trading day, Elevance Health (ELV) stood at $475.12, denoting a -1.49% change from the preceding trading day.

Here's Why Elevance Health (ELV) is a Strong Value Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Elevance Health (ELV) & Verizon Partner to Bring Health Equity

by Zacks Equity Research

Elevance Health (ELV) launches a new program with an Affordable Connectivity Program offering free smartphones to eligible members.

Elevance Health (ELV) Enhances Whole Health With Paragon Buyout

by Zacks Equity Research

Elevance Health (ELV) agrees to acquire Paragon Healthcare, boosting its capabilities in specialty pharmacy.

Is Cigna (CI) Nearing a Medicare Advantage Divestment Deal?

by Zacks Equity Research

Cigna's (CI) Medicare Advantage unit's divestment is expected to fetch around $3-$4 billion.

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why You Should Retain Centene (CNC) Stock For Now

by Zacks Equity Research

Centene (CNC) remains well-poised for growth on the back of overall membership growth, acquisitions, business streamlining efforts and a growing cash balance.

The Zacks Analyst Blog Highlights Medpace, Elevance Health and HealthEquity

by Zacks Equity Research

Medpace, Elevance Health and HealthEquity are part of the Zacks top Analyst Blog

Urmimala Biswas headshot

3 Amazing Health Service Stocks to Brave "Labordemic" in 2024

by Urmimala Biswas

Here are the three stocks, MEDP, ELV and HQY, which have the potential to shield your portfolio from the impact of healthcare staffing challenges in 2024.

ELV vs. GDRX: Which Stock Is the Better Value Option?

by Zacks Equity Research

ELV vs. GDRX: Which Stock Is the Better Value Option?

Elevance Health (ELV) Stock Falls Amid Market Uptick: What Investors Need to Know

by Zacks Equity Research

Elevance Health (ELV) concluded the recent trading session at $465.78, signifying a -0.76% move from its prior day's close.

Cigna's (CI) Medicare Advantage Unit Draws Acquisition Interest

by Zacks Equity Research

The final bids for Cigna's (CI) Medicare Advantage unit are expected next week.

Here's Why Investors Should Hold Elevance (ELV) Stock for Now

by Zacks Equity Research

Elevance's (ELV) Carelon unit will see growth due to improving performance in post-acute care services and Behavioral Health business.

Elevance Health (ELV) Rises Yet Lags Behind Market: Some Facts Worth Knowing

by Zacks Equity Research

In the latest trading session, Elevance Health (ELV) closed at $488.06, marking a +0.94% move from the previous day.

Why Elevance Health (ELV) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Elevance Health (ELV) Stock Slides as Market Rises: Facts to Know Before You Trade

by Zacks Equity Research

Elevance Health (ELV) closed the most recent trading day at $476.96, moving -0.28% from the previous trading session.